Patent ID: 8852589
Filing Date: 2014-10-07
Classification: A61K,A61P,C07K

Abstract:
1. A method for the treatment or reduction of inflammatory bowel disease, said method comprising administering to a subject in need thereof an effective amount of an antibody molecule which binds IL-17BR and which comprises an antibody VH domain comprising a CDR1 having an amino acid sequence as set out in SEQ ID NO:5, a CDR2 having an amino acid sequence as set out in SEQ ID NO:6, and a CDR3 having an amino acid sequence as set out in SEQ ID NO:7, and an antibody VL domain with a CDR1 having an amino acid sequence as set out in SEQ ID NO:8, a CDR2 having an amino acid sequence as set out in SEQ ID NO:9, and a CDR3 having an amino acid sequence as set out in SEQ ID NO:10, optionally in a pharmaceutically acceptable carrier.